ODI Pharma AB (FRA:6OD) Other Financing: €0.00 Mil (TTM As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:6OD ODI Pharma AB FRA:6OD
46 GF Score
Price €0.20
GF Value €0.72
View Full Analysis

What is ODI Pharma AB Other Financing?

ODI Pharma AB FRA:6OD +12.36% 46 Other Financing is €0.00 Mil as of Mar. 2026. GuruFocus rates FRA:6OD with a GF Score™ of 46/100 and a GF Value™ of €0.72.

ODI Pharma AB's Other Financing for the three months ended in Mar. 2026 was €0.00 Mil.

ODI Pharma AB's Other Financing for the trailing twelve months (TTM) ended in Mar. 2026 was €0.00 Mil.

ODI Pharma AB Other Financing Historical Data

* Premium members only.

The historical data trend for ODI Pharma AB's Other Financing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

ODI Pharma AB Other Financing Chart

ODI Pharma AB Annual Data
Trend Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
Other Financing
Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

ODI Pharma AB Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Other Financing Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
FRA:6OD
46GF Score
ODI Pharma AB FRA:6OD
Other Financing is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

ODI Pharma AB Other Financing Calculation

Other Financing represents other cash flow from financing activity that not otherwise classified, which includes:
Proceeds From Stock Option Exercised
Other Financing Charges

Other Financing for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Other Financing →
What does a Other Financing of €0.00 Mil mean?
ODI Pharma AB (FRA:6OD) has a Other Financing of €0.00 Mil as of Mar. 2026. Other Financing represents other cash flow from financing activity that not otherwise classified. View historical data for ODI Pharma AB and its competitors.
Is ODI Pharma AB's Other Financing too high?
ODI Pharma AB's current Other Financing is €0.00 Mil. Overall, ODI Pharma AB has a GF Score™ of 46/100, reflecting its overall financial health beyond just this single metric.
How does ODI Pharma AB's Other Financing compare to ZTS and UTHR?
ODI Pharma AB's Other Financing of €0.00 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Financing for a Drug Manufacturers company?
A good Other Financing depends on the Drug Manufacturers industry context. However, Other Financing should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Financing mean?
A high Other Financing can signal that a stock is expensive relative to its fundamentals. Other Financing represents other cash flow from financing activity that not otherwise classified. View historical data for ODI Pharma AB and its competitors. ODI Pharma AB's current Other Financing is €0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is ODI Pharma AB stock overvalued right now?
ODI Pharma AB (FRA:6OD) has a current Other Financing of €0.00 Mil. The stock's GF Value™ is €0.72, compared to a current price of €0.20 — trading 72.2% below its estimated fair value. The current Other Financing is €0.00 Mil. ODI Pharma AB's overall GF Score™ is 46/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Financing calculated?
Other Financing is calculated from a company's financial statements. For ODI Pharma AB (FRA:6OD), the current Other Financing is €0.00 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is ODI Pharma AB (FRA:6OD) Overvalued in 2026?

Based on GuruFocus' analysis, ODI Pharma AB stock appears to be undervalued. The current stock price of €0.20 is trading 72.2% below its estimated GF Value™ of €0.72.

Key valuation signals for FRA:6OD:

  • Other Financing: €0.00 Mil
  • GF Value™: €0.72 vs. price of €0.20 (72.2% below fair value)
  • GF Score™: 46/100

No single metric tells the full story. See the FRA:6OD stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

ODI Pharma AB Business Description

Other Exchanges ODI:Sweden
Address Ostermalmstorg 1, Stockholm, SWE, 114 42
ODI Pharma AB is a provider of medicinal cannabis. It offers its products to pharmacies, specialty clinics, and hospitals.
46GF Score

Get the complete analysis for FRA:6OD

Other Financing is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.20
Price
€0.72
GF Value